Evidence map›Paper›PMID 15668700›Full record

ArticleLeukemia2005

Disruption of the BCL11B gene through inv(14)(q11.2q32.31) results in the expression of BCL11B-TRDC fusion transcripts and is associated with the absence of wild-type BCL11B transcripts in T-ALL.

G K Przybylski, W A Dik, J Wanzeck, P Grabarczyk, S Majunke, J I Martin-Subero, R Siebert, G Dölken, W-D Ludwig, B Verhaaf and 3 more

Abstract read
PubMed Publisher
In one paragraph

Article in Leukemia, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed
9.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 122 citations in OpenAlex.

  1. Trial
  2. Article
  3. Dual role ofBlood science (Baltimore, Md.) · 2024
    Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Generation of InducibleInternational journal of molecular sciences · 2022
    Article
  9. Article
  10. Article
  11. Novel targeted therapies of T cell lymphomas.Journal of hematology & oncology · 2020
    Review
  12. Article
  13. Bcl11b/Ctip2 in Skin, Tooth, and Craniofacial System.Frontiers in cell and developmental biology · 2020
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 3 countries.

G K PrzybylskiInstitute of Human Genetics, Polish Academy of Sciences, Poznan, Poland. przybylg@man.poznan.pl
W A Dik
J Wanzeck
P Grabarczyk
S Majunke
J I Martin-Subero
R Siebert
G Dölken
W-D Ludwig
B Verhaaf
J J M van Dongen
C A Schmidt
A W Langerak
Universitätsmedizin Greifswald · DEErasmus MC · NLUniversity of Lübeck · DECharité - Universitätsmedizin Berlin · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

T-cell acute lymphoblastic leukemia (T-ALL) is associated with chromosomal aberrations characterized by juxtaposition of proto-oncogenes to T-cell receptor gene loci (TCR), resulting in the deregulated transcription of these proto-oncogenes. Here, we describe the molecular characterization of a novel chromosomal aberration, inv(14)(q11.2q32.31), in a T-ALL sample, involving the recently described BCL11B gene and the TCRD locus. The inversion joined the 5' part of BCL11B, including exons 1-3, to the TRDD3 gene segment of the TCRD locus, whereas the reciprocal breakpoint fused the TRDV1 gene segment to the fourth exon of BCL11B. The TRDV1-BCL11B joining region was 1344 bp long and contained fragments derived from 20q11.22, 3p21.33 and from 11p12, indicating the complex character of this aberration. A strong expression of in-frame transcripts with truncated BCL11B and TCRD constant region (TRDC) were observed, but in contrast to normal T cells and other T-ALL samples, no wild-type BCL11B transcripts were detected in the T-ALL sample. Screening of 37 other T-ALLs revealed one additional case with expression of the BCL11B-TRDC fusion transcript. As BCL11B appears to play a key role in T-cell differentiation, BCL11B disruption and disturbed expression may contribute to the development of T-cell malignancies in man.

Indexed as

Chromosomes, Human, Pair 11Chromosomes, Human, Pair 14Translocation, GeneticBase SequenceChromosome MappingDNA-Binding ProteinsGene DeletionHumansLeukemia-Lymphoma, Adult T-CellMolecular Sequence DataRepressor ProteinsTranscription, GeneticTumor Suppressor ProteinsBCL11B protein, humanDNA-Binding ProteinsRepressor ProteinsTumor Suppressor Proteins

Identifiers

PMID15668700
OpenAlexW1990125381

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.